Litts Drug Eruption & Reaction Database - Presented by CRC Press

Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.Litt's Development Team


Log in
In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Continue
Menu
Login
  • Home
  • About About
    • About the Database
    • About the Book
    • Related Products
    • About Dr Litt
    • About Dr Shear
  • Alerts
  • Litt’s App
  • Contact Us
  • Help
  • Subscribe Subscribe
    • Individual Subscription
    • Institutional Subscription

Drugs belonging to  restart save

class – Covid-19 putative drug – 32 items found

  • show all
  • 0–9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Anakinra

Ascorbic Acid

Azithromycin

Baricitinib

Bevacizumab

Chloroquine

Colchicine

Daclatasvir

Darunavir

Dexamethasone

Eculizumab

Emapalumab

Fingolimod

Granulocyte Colony-Stimulating Factor (G-CSF)

Hydroxychloroquine

Immune Globulin IV

Interferon Beta

Ivermectin

Ledipasvir & Sofosbuvir

Lopinavir


Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Covid-19 putative drug'

Please login to view adverse reactions.

Cutaneous adverse reaction (includes severe cutaneous adverse drug reaction (SCAR))

    • (2020): Tursen U+, Dermatol Ther May, Epub ahead of print [REVIEW]

Cardiovascular adverse effect (includes major adverse cardiovascular events (MACE))

    • (2022): Hamidian M+, J Res Med Sci 27, 92 [REVIEW] (with underlying comorbidities)
    • (2020): Carpenter A+, Front Cardiovasc Med 7, 85 [REVIEW]
    • (2020): Giudicessi JR+, Mayo Clin Proc May, Online ahead of print [REVIEW]
    • (2020): Naksuk N+, Eur Heart J Acute Cardiovasc Care May, Epub ahead of print [REVIEW]
    • (2020): Sarayani A+, Res Social Adm Pharm Apr, Epub ahead of print [REVIEW]
    • (2020): Zhang D+, Zhongguo Zhong Yao Za Zhi (Chinese) 45(10), 2275-2286 [REVIEW]

Neuropsychiatric / neuropsychological adverse effect

    • (2021): Borah P+, Front Mol Biosci 8, 627723
    • (2020): García CAC+, Gen Hosp Psychiatry Jun, Online ahead of print [REVIEW]

Gastrointestinal disorder / discomfort

    • (2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print23%

Hepatic (liver) disorder / hepatobiliary disorder / hepatic (liver) dysfunction

    • (2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print14%

Thrombocytopenia / platelets decreased

    • (2020): Nham E+, Infect Chemother Apr, Epub ahead of print

Adverse effects / adverse reactions

    • (2023): Alsuhaibani DS+, Saudi Pharm J 31(7), 1360-1366
    • (2022): Aguilera C+, Diagnostics (Basel) 12(7), 1612
    • (2022): Chiu MN+, Eur J Clin Pharmacol Jan, Online ahead of print [REVIEW]
    • (2022): Diak IL+, Drug Saf Dec, Online ahead of print [REVIEW]
    • (2021): Bérard A+, PLoS One 16(5), e0251746 [REVIEW] (in pregnancy)
    • (2021): Bao S+, Ann Transl Med 9(15), 1229 [REVIEW]
    • (2021): Cheng Q+, Aging (Albany NY) Sep, Online ahead of print [REVIEW]
    • (2021): Cruciani F+, Recenti Prog Med 112(3), 195-206 [REVIEW]
    • (2021): Drożdżal S+, Drug Resist Updat Dec (e-Collection) [REVIEW]
    • (2021): Ommati MM+, J Biochem Mol Toxicol May, Online ahead of print [REVIEW]
    • (2021): Qiu R+, Medicine (Baltimore) 100(16), e25532 [REVIEW]
    • (2021): Wu SS+, Chin Med J (Engl) Jul, Online ahead of print [REVIEW]
    • (2020): Favilli A+, J Matern Fetal Neonatal Med Jun, Online ahead of print [REVIEW]
    • (2020): Griffiths G+, Trials 21(1), 544
    • (2020): Patil VM+, Life Sci May, Epub ahead of print [REVIEW]
    • (2020): Rhodes NJ+, medRxiv Jun, Preprint
    • (2020): Sun J+, Clin Pharmacol Ther Apr, Epub ahead of print38%
    • (2020): Svensson M, Lakartidningen (Swedish) Apr, 117
    • (2020): Wen CY+, Zhonghua Nei Ke Za Zhi (Chinese) May, Epub ahead of print
    • (2020): Zekarias A+, Drug Saf Sep, Online ahead of print [REVIEW]
    • (2020): Zhong H+, Pharmacol Res Apr, Epub ahead of print [REVIEW]

Saved Searches Watched Drugs
Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Back to top
  • Help
  • Terms & Conditions
  • Privacy
  • Disclaimer
  • Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.